Default company panoramic image

nSens LLC

Merger of 2 existing early stage instrument manufacturers with well-positioned product lines for proteomics research with no technology risk

  • Stage Full Product Ready
  • Industry Electronics / Instrumentation
  • Location Fort Erie, ON, Canada
  • Currency USD
  • Founded January 2014
  • Employees 2

Company Summary

nSens has core expertise in guided wave laser sensing, microfluidics & bioinformatics combining scattering & spectroscopy to size biologically important nanomaterials at ultra-low concentration. Products designed to accelerate early stage drug discovery by reducing analytical bottlenecks, and as platforms for diagnostic assays used by biotech & biopharmaceutical research labs. Global market exceeded $725M in 2012 driven by growth in proteomics.


  • Default avatar
    John Hayes
    CEO & CFO

    30 years operating & financial experience in seed/early stage ventures, 10 as Principal/Treasurer of Venture Founders, an early stage VC firm specializing in high technology venture investments. This experience in venture capital, coupled with 25 years as Founder/CEO of Sensor Technologies & BioHybrid Technologies provides nSens with expertise in venture management, equity fund-raising and execution of strategic partnering & commercialization.

  • Default avatar
    Roger White
    CSO & Marketing Director

    PhD in Materials Science lead to a 27 year career in analytical instruments, initially in research then HPLC sales/marketing with Waters.Variety of high profile sales, marketing & entrepreneurial management roles in lab robotics & polymer analysis lead to founding analytical instruments importer, global contract analysis and R&D business with offices in UK, US & Canada, global distribution network & research collaborations across Europe & Canada